Faster, cheaper, animal-free: start-up aims to revolutionise drug development
Start-up prize for "EmbryoNet AI Technologies"
Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for their business concept.

Patrick Müller is Professor of Developmental Biology at the Department of Biology at the University of Konstanz and an associate member of the Konstanz Cluster of Excellence ‘Collective Behaviour’
Jörg Abendroth
Developing new drugs is a very time-consuming and expensive process that still requires animal testing. The start-up EmbryoNet AI Technologies wants to use artificial intelligence (AI) to revolutionize the process. The team is led by Patrick Müller, a professor in the Department of Biology at the University of Konstanz and an affiliate member of the Konstanz Cluster of Excellence "Collective Behaviour". At the moment, they are developing an online platform that enables automated drug screening in animal embryos or artificial organoids while identifying the underlying mechanisms of how the substances work.
The AI-supported method is faster, more cost-effective and more sustainable than current means of drug development. EmbryoNet AI Technologies aims to work with pharmaceutical companies, research institutions and regulators to improve the efficiency of their research as well as to enable them to move towards animal-free drug testing.
The business concept of Embryonet AI Technologies was one of the 15 winning concepts selected by the Federal Ministry for Economic Affairs and Climate Action in the start-up competition. Each winner receives 7,000 euros as well as individual coaching services. The award ceremony took place on 19 March 2025 at the networking event "Connecting the Dots" in Berlin.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.